GRACE :: Lung Cancer » Subject Archives

Subject Archives
General (24)
Lung Cancer (276)
- Core Concepts (86)
  - Bronchioloalveolar Carcinoma (BAC) (10)
  - Early Stage NSCLC & Surgery (19)
  - Locally Advanced (Stage III) NSCLC (13)
  - Metastatic/Recurrent NSCLC, First Line (12)
  - Metastatic/Recurrent NSCLC, Second Line and Later (9)
  - Never-Smokers with Lung Cancer (4)
  - SCLC, Extensive Disease and Recurrent (9)
  - SCLC, Limited Disease (5)
  - Targeted Therapies, Activity and Side Effects (22)
- Current Clinical Trials (43)
- General Lung Cancer Issues (249)
  - Causes of Lung Cancer & Prevention Strategies (7)
  - Evaluation and Work-Up (24)
  - Gene Profiles/Molecular Signatures (11)
  - Imaging and Response Measurement (14)
  - Management of Bone Metastases (3)
  - Management of Brain Metastases (10)
  - Management of Pleural Effusions (2)
  - Miscellaneous Other Problems from Lung Cancer (4)
  - Pathology/Lung Cancer Subtypes (21)
  - Screening Issues and Controversy (7)
  - Smoking Cessation/Tobacco Control (2)
  - Supportive care (6)
  - Treatment (198)
    - Chemotherapy (102)
    - Radiation therapy (35)
    - Surgery Issues (44)
    - Targeted therapies (99)
      - Anti-angiogenic agents (24)
      - Epidermal growth factor receptor (EGFR)-based therapies (70)
        
        Clinical variables in EGFR therapy (20)
        
        EGFR mutations and other molecular markers (25)
        
        Rash and other side effects (9)
      - Immune/Vaccine-based therapies (3)
      - Multikinase inhibitors (8)
      - Other targeted therapies (6)
- Mesothelioma (4)
- Non-Small Cell Lung Cancer (NSCLC) (185)
  - Early Stage NSCLC (Stage I/II) (39)
  - Stage III/Locally Advanced NSCLC (52)
    - Resectable locally advanced NSCLC (26)
    - Unresectable locally advanced NSCLC (22)
  - Stage IV/Advanced/Metastatic NSCLC (110)
    - First-line treatment (65)
    - Second-line treatment (54)
    - Third-line therapy and beyond (30)
- Small Cell Lung Cancer (SCLC) (35)
  - Extensive Disease Small Cell Lung Cancer (ED-SCLC) (27)
  - Limited Disease Small Cell Lung Cancer (LD-SCLC) (12)
- Special Populations in Lung Cancer (50)
  - Bronchioloalveolar Carcinoma (BAC) (22)
  - Never-smokers with lung cancer (12)
  - Older and/or frail patients with lung cancer (13)
  - Pancoast Tumors (3)
  - Sex-based differences in lung cancer (8)